Works by Lee, K.


Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8

    The trends in epidemiology, characteristics and initial managements of pediatric inflammatory bowel disease: a multicenter study for recent 3 years including the era of COVID-19.

    Published in:
    Journal of Pediatric Gastroenterology & Nutrition, 2022, v. 74, p. 508, doi. 10.1097/MPG.0000000000003446
    By:
    • Choi, S. Y.;
    • Choi, S.;
    • Kang, B.;
    • Choe, B. H.;
    • Lee, Y. J.;
    • Park, J. H.;
    • Kim, Y. B.;
    • Kim, J. Y.;
    • Lee, K.;
    • Lee, K. J.;
    • Kang, K. S.;
    • Lee, Y. M.;
    • Kim, H.;
    • Kang, Y.;
    • Jang, H. J.;
    • Yi, D. Y.;
    • Hong, S. J.;
    • Choi, Y. J.;
    • Hong, J.;
    • Kim, S. C.
    Publication type:
    Article
    9
    10

    Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.

    Published in:
    Diabetes, Obesity & Metabolism, 2015, v. 17, n. 6, p. 599, doi. 10.1111/dom.12435
    By:
    • Jin, S.‐M.;
    • Park, C.‐Y.;
    • Cho, Y. M.;
    • Ku, B. J.;
    • Ahn, C. W.;
    • Cha, B.‐S.;
    • Min, K. W.;
    • Sung, Y. A.;
    • Baik, S. H.;
    • Lee, K. W.;
    • Yoon, K.‐H.;
    • Lee, M.‐K.;
    • Park, S. W.
    Publication type:
    Article
    11

    Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension.

    Published in:
    Diabetes, Obesity & Metabolism, 2015, v. 17, n. 5, p. 511, doi. 10.1111/dom.12429
    By:
    • Jin, S.‐M.;
    • Park, S. W.;
    • Yoon, K.‐H.;
    • Min, K. W.;
    • Song, K.‐H.;
    • Park, K. S.;
    • Park, J.‐Y.;
    • Park, I. B.;
    • Chung, C. H.;
    • Baik, S. H.;
    • Choi, S. H.;
    • Lee, H. W.;
    • Lee, I.‐K.;
    • Kim, D.‐M.;
    • Lee, M.‐K.
    Publication type:
    Article
    12

    A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2010, v. 12, n. 12, p. 1113, doi. 10.1111/j.1463-1326.2010.01303.x
    By:
    • Rhee, E. J.;
    • Lee, W. Y.;
    • Yoon, K. H.;
    • Yoo, S. J.;
    • Lee, I. K.;
    • Baik, S. H.;
    • Kim, Y. K.;
    • Lee, M. K.;
    • Park, K. S.;
    • Park, J. Y.;
    • Cha, B. S.;
    • Lee, H. W.;
    • Min, K. W.;
    • Bae, H. Y.;
    • Kim, M. J.;
    • Kim, J. A.;
    • Kim, D. K.;
    • Kim, S. W.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Non-traumatic ischiorectal Epidermoid Cyst.

    Published in:
    Hong Kong Journal of Radiology, 2018, v. 21, n. 1, p. 54, doi. 10.12809/hkjr1616403
    By:
    • Lee, G. K. Y.;
    • Lee, K. H.;
    • Chu, C. Y.;
    • L. Li, H.;
    • Khoo, J. L. S.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Visceral fat and cardiovascular risk factors in Chinese NIDDM patients.

    Published in:
    1997
    By:
    • Anderson, Patricia J.;
    • Chan, Juliana C. N.;
    • Chan, Y. L.;
    • Tomlinson, Brian;
    • Young, Robert P.;
    • Lee, Zoe S. K.;
    • Lee, Kenneth K. C.;
    • Metrewell, Constantine;
    • Cockram, Clive S.;
    • Critchley, Julian A. J. H.;
    • Anderson, P J;
    • Chan, J C;
    • Tomlinson, B;
    • Young, R P;
    • Lee, Z S;
    • Lee, K K;
    • Metreweli, C;
    • Cockram, C S;
    • Critchley, J A
    Publication type:
    journal article
    50